Skip to content
‹ Back to IndustriesHealthcare

The Future of Fiber Optics Is Looking Bright

What kind of industry could potentially have a compound annual growth rate (CAGR) of around 9% over the next decade? The answer: the global fiber optics market. That would mean by 2025, the fiber optic market could be worth approximately $7.52 billion. There is little question that the future is looking bright for fiber optics….

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

·
Share

Free workspace

Turn your Healthcare expertise into content.

Record interviews, organize footage, and write with AI on a free trial of the MarketScale platform for qualifying companies. No demo required, no credit card.

Try it Free

What kind of industry could potentially have a compound annual growth rate (CAGR) of around 9% over the next decade? The answer: the global fiber optics market. That would mean by 2025, the fiber optic market could be worth approximately $7.52 billion. There is little question that the future is looking bright for fiber optics.

What will drive all of this growth? The primary mainspring is the need for high bandwidth in the maritime environment, the healthcare industry, technological advancements, and upgrades to current systems. Increasing demand for high-speed internet is driving the demand for high-speed fiber optics systems, including higher-capacity optical fibers and system components like optical amplifiers. Everyone wants more bandwidth, and fiber optics is proving it can deliver.

Fiber Optics, VDSL, and Home Demand for High-Speed Internet

Rising internet speeds has led to an increase in demand for Fiber to the Home (FTTH). If anything can slow the growth of fiber optics, though, it’s competition from the latest development in DSL to VDSL. Glass and plastic optical fibers are competing against copper wire, but with the rising prices of copper, it is likely that fiber optics will remain competitive.

Temperature Sensors

One place where fiber optics remains vital is the temperature sensors market. This market is expected to grow by nearly 6% over the next five years, from $5.62 billion in 2018 to $7.48 billion in 2023. Growth is expected from their use in the chemical, consumer electronics (like wearables and smartphones), oil and gas, energy and power, and automotive industries.

Optical Amplifiers

Optical amplifiers are a central component to fiber optics systems, and as the demand for fiber optics increases, so will demand for optical amplifiers. In fact, it’s predicted that the optical amplifier market will grow by around $936 million between 2019 and 2023, averaging a 9% CAGR that keeps step with the projected 9% growth for fiber optical systems. Long- and ultra-long-haul (from cities to continents) networks that amplify signal transmission over long distances will likely be a key growth driver in this sector.

Let Fiberguide Industries Be Your Guide to a Fiber Optical Future

For more than three decades, Fiberguide Industries has been a reliable, long-term strategic partner with OEM manufacturers in providing efficient, cost-effective, practical fiber optic solutions engineered to meet their specific needs. Specializing in manufacturing large core specialty optical fiber and high temperature metalized optical fibers, Fiberguide packages their fibers in a variety of assemblies/bundles to meet the requirements of diverse optical power delivery and optical sensing applications. With corporate headquarters and fiber manufacturing located in Stirling, New Jersey, applications engineering, component, and assembly manufacturing in Caldwell, Idaho, and a sales office and manufacturing in Shanghai, China, Fiberguide Industries is well positioned to serve the needs of their customers globally.

To learn more about how Fiberguide can help guide you to better optical fiber solutions, contact us at https://www.fiberguide.com/ today!

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Book DemoSee how it works15 minutes, straight to a calendar.
B2B Weekly

The week in Healthcare, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free Trial

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Start a free trial and see it with your own people. For qualifying companies, no credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What your free trial includes

Hands-on access to the MarketScale platform
Media requests to your crowd, remote recording, AI writing tools
No demo required. No credit card.
For qualifying companies. Company confirmation required.

More Healthcare Insights

Johns Hopkins' Ritu Agarwal wants hospitals to measure a baseline before scaling AI

Johns Hopkins' Ritu Agarwal wants hospitals to measure a baseline before scaling AI

A Google Cloud survey found that only 30% of healthcare organizations have scaled advanced or agentic AI across their operations. Johns Hopkins professor Ritu Agarwal says health systems need a measured baseline, clinician-led workflow design and representative data before they scale. Small pilots hide the rest.

  • 01A 200-person pilot answers whether a tool works; how it behaves on another hospital's patients and what it costs at full volume mostly show up after the pilot ends.
  • 02Just 30% of healthcare organizations said they’ve scaled advanced or agentic AI across operations, according to a Google Cloud survey of 250+ healthcare executives.
  • 03The sharper pre-pilot question: which disease condition, which baseline metric and what projected cost at full volume will this tool be judged against?

Nov 18, 2026

Sterile processing deviations become the norm without stop-and-document rules

Sterile processing deviations become the norm without stop-and-document rules

Advanced Sterilization Products' Tamara Beeler told Censis Technologies' CtUC 2026 audience that sterile processing deviations harden into norms when departments don’t stop, escalate and document them. She connects ANSI/AAMI ST108:2023 water categories, daily cleaning verification, loaner-tray refusal when sets arrive late or lack IFUs, and root cause analysis when rework repeats on the same device.

  • 01ANSI/AAMI ST108:2023 turned water quality for instrument reprocessing into an enforceable standard; AAMI's earlier TIR34 was guidance with no enforcement behind it.
  • 02Some facilities require loaner trays 48 hours before a case, and ASP's Tamara Beeler says a technician at any level can refuse one that arrives late, undocumented or dirty.
  • 03Rework that returns on the same device is the point at which Beeler wants a root cause analysis opened, with the record kept in the instrument tracking system.

Nov 17, 2026

TheraPanacea aims to spread best-center radiotherapy quality

TheraPanacea aims to spread best-center radiotherapy quality

TheraPanacea CEO Nikos Paragios says the company's two objectives are to carry best-center radiotherapy quality to every patient and to pick each patient's treatment at the start from multimodal data. A 2026 Nature Communications trial of 500 patients found AI-assisted contouring lifted mean Dice overlap from 0.857 to 0.902, and Siemens Healthineers CE-marked its own AI contouring in May 2026.

  • 01TheraPanacea's two stated objectives: carry best-center radiotherapy quality to every patient on the globe, and identify each patient's best treatment at the start from imaging and clinical history.
  • 02A 2026 Nature Communications trial of 500 patients across five centers found AI-assisted contouring lifted mean Dice overlap from 0.857 to 0.902 and cut median contouring time from 55 to 10 minutes, with less variation between centers.
  • 03Siemens Healthineers' Varian business CE-marked AI contouring for Eclipse in May 2026, so Paragios locates TheraPanacea's edge in its team, hospital partnerships and impact focus rather than in the algorithm alone.

Nov 17, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a Demo

Or call us. No forms required. We pick up. 214-945-2512